| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/01.WNL.0000034766.13282.33 |
| P698 | PubMed publication ID | 12451224 |
| P50 | author | Michael D. Hill | Q37830493 |
| P2093 | author name string | Martin L | |
| Bell RB | |||
| Zochodne DW | |||
| Pettersen JA | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cerebral sarcoidosis | Q18554509 |
| P304 | page(s) | 1660-1661 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Refractory neurosarcoidosis responding to infliximab. | |
| P478 | volume | 59 |
| Q33166469 | A rare comorbidity: neurosarcoidosis and cutaneous sarcoidosis |
| Q38818458 | Biologic therapies in the treatment of sarcoidosis |
| Q40837020 | Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients. |
| Q34636680 | Current and emerging strategies for the management of sarcoidosis |
| Q34312001 | Dramatic response to infliximab in refractory neurosarcoidosis |
| Q84979076 | Headache attributed to non-vascular intracranial disorder |
| Q35729575 | Immune mediated diseases and immune modulation in the neurocritical care unit |
| Q36262452 | Inflammatory neuropathies: an update on evaluation and treatment |
| Q46271418 | Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series |
| Q83815513 | Infliximab for treating sarcoidosis patients, Portuguese experience |
| Q34996785 | Infliximab therapy for hepatic and intestinal sarcoidosis. |
| Q38049882 | Intramedullary spinal sarcoidosis masquerading as cervical stenosis |
| Q40308372 | Long-term outcomes of refractory neurosarcoidosis treated with infliximab |
| Q37910659 | Long-term treatment with infliximab in patients with sarcoidosis |
| Q37867190 | Medically refractory neurosarcoidosis treated with infliximab |
| Q36724093 | Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines |
| Q79748001 | Neuro-ophthalmologic Manifestations of Sarcoidosis |
| Q80184825 | Neurosarcoidosis |
| Q80918459 | Neurosarcoidosis |
| Q37206778 | Neurosarcoidosis in a Tertiary Referral Center: A Cross-Sectional Cohort Study |
| Q35811051 | Neurosarcoidosis: a clinical dilemma |
| Q38202643 | Neurosarcoidosis: clinical review of a disorder with challenging inpatient presentations and diagnostic considerations |
| Q34236242 | Neurosarcoidosis: guidance for the general neurologist. |
| Q44647059 | Refractory Sarcoidosis Responding to Infliximab * |
| Q36507399 | Sarcoidosis of the spinal cord: literature review and report of eight cases |
| Q46146355 | Spinal cord sarcoidosis: report of seven cases |
| Q33403151 | Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil |
| Q37886194 | Tumor necrosis factor biologics beyond psoriasis in dermatology |
| Q24652971 | Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis |
| Q80202594 | [Neurosarcoidosis treated with mycophenolate mofetil: two cases] |
| Q79411734 | [Neurosarcoidosis] |
| Q79949492 | [Off-label use of biologic agents in the treatment of dermatosis, Part 1: infliximab and adalimumab] |
| Q81161245 | [Update on sarcoidosis] |
Search more.